symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
ENVB,2.11,0.212792,84442,4603830,18490.500000000022,1.3-6.98,0.04,"Enveric Biosciences, Inc.",USD,0000890821,,29405E208,NASDAQ Capital Market,NASDAQ,Biotechnology,https://www.enveric.com,"Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.",Dr. Joseph Edward Tucker Ph.D.,Healthcare,US,25,239 302 1707,4851 Tamiami Trail North,Naples,FL,34103,,0,https://financialmodelingprep.com/image-stock/ENVB.png,2015-05-04,False,False,True,False,False
